Additional file 1 of Monitoring trends in the absolute lymphocyte count and the neutrophil-to-lymphocyte ratio in patients with breast cancer receiving eribulin

Additional file 1: Supplementary Figure 1. Overall survival (OS) among patients with increased or decreased trends of ALC, NLR (0: decreasing, 1: non-decreasing). Supplementary Figure 2. Comparing PFS and OS among different groups of patients stratified by ALC trends according to the baseline level. Supplementary Figure 3. Comparing PFS and OS among different groups of patients stratified by NLR baseline and trends. Supplementary Figure 4. Analysis on the association of high(1)/low(0) NLR/ALC with OS stratified by on(1)/off(0) treatment with eribulin.